Overview

suPAR to Guide Antibiotics in Emergency Department

Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
The aim of the current study is to evaluate suPAR - guided medical intervention, consisting of early antibiotic administration at the emergency room for presumed infection and sepsis and evaluate the impact of this intervention to the patients' final outcome. Since the traditionally used biomarkers (PCT, CRP) and scores (SOFA score) for early recognition of severity of infection fail to achieve maximum accuracy in all cases, suPAR levels are assessed as a probably better prognostic rule for early recognition of severe infections. The primary study endpoint will be the comparative efficacy of the early suPAR-guided administration of antibiotics versus standard practice on 28-day mortality.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hellenic Institute for the Study of Sepsis
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Meropenem